Significant Research and Development Grants for the Development of Tuberculosis Tests and the Rising Prevalence Of Tuberculosis is Anticipated To Drive The Market Growth

According to the report, the tuberculosis testing market is projected to reach US$ 3,179.9 Mn in 2025 at a CAGR of 3.9% from 2017 to 2025.The report provides detailed analysis of the current and emerging trends in the tuberculosis testing market. The market size has been provided for test type, end-user, and geography. The report provides forecasts for revenue (US$ Mn) from 2017–2025. Tuberculosis (TB) has exist for periods and remains a main universal health issues. It causes bad health in millions of persons every year. In year 2015, tuberculosis is one of the top 10 death causes worldwide, position over the HIV AIDS as one of the major reasons of death by an infectious disease. As per the report published by WHO, in year 2015, there were an estimated 10.4 Mn new (incident) tuberculosis cases globally, of which around 5.9 Mn (56%) were amongst men, around 3.5 Mn (34%) amongst women and around 1.0 Mn (10%) amongst children. Persons with HIV estimated for around 1.2 Mn (11%) of all new TB cases.

Read Report - https://www.transparencymarketresearch.com/tuberculosis-testing-market.html

Globally six countries accounted for 60% of the new tuberculosis cases such as South Africa, Pakistan, Nigeria, China, Indonesia, and India. Global growth depends on main advances in care and prevention of tuberculosis in these countries. Globally, the rate of drop in tuberculosis incidence stayed at only 1.5% since 2014 to 2015. According to report published by WHO, in 2015 around 480,000 new cases of multidrug resistant tuberculosis (MDR-TB) and an in addition around 100,000 persons with rifampicin resistant tuberculosis (RR-TB) who were too again entitled for MDR-TB treatment. The Russian Federation, China, and India accounted for 45% of the collective total of 580,000 cases.

Inquire for a Sample Copy of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2267

Based on test type, the market has been segmented into chest x-ray, culture based tests, IGRA (interferon-gamma release assays), mantoux test (TST), nucleic acid testing (NAT), Xpert test, serological tests, smear microscopy and other tests (ADA, etc.). Culture based tests was the dominant segment in 2016 and is anticipated to remain dominant in the forecast period, in terms of revenues. The strong growth of the segment can be attributed due to the cost effectiveness of the test, accuracy and also ease of performance. Culture test is considered a gold standard for TB diagnostic tests that utilize sputum or other clinical specimens. Culture tests include collection of sputum or other specimens, followed by inoculation on a solid or liquid culture medium. This is followed by incubation and bacterial identification. The IGRA (Interferon-Gamma Release Assays) segment is anticipated to grow at a significant high CAGR during the forecast period. IGRA (Interferon-Gamma Release Assay) is a whole-blood test that is a relatively new diagnostic tool for diagnosis of latent infection caused by Mycobacterium tuberculosis. The growth in the segment can be attributed due to the advantages of IGRA tests are: a) single patient visit, b) rapid detection (within 24 hours), and c) no chance of misdiagnosis if BCG vaccine previously taken.

Download a PDF Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2267

On the basis of end-user, the market has been segmented into Academics and Research, Hospitals Laboratories, Physician's Office Laboratories, Reference Laboratories, Others (Home Health Agencies, etc.). Hospital laboratories segment dominated the market in 2016 in terms of revenues, and the trend is anticipated to continue in the forecast period. The growth in the hospital laboratories can be attributed due to the cost effective tests available in hospital laboratories. In addition, the increasing hospitalization for the treatment of tuberculosis, the ease of availability of products in hospital laboratories, and the growing alignment between hospitals and physicians aids in the growth of the segment in the forecast period. The physician's office laboratories segment is anticipated to grow at a significant high CAGR in the forecast period. The growth of the segment can be attributed to increasing reach of patients to the physician’s, the growing number of these facilities globally, and other services such as cost containment offered by these laboratories. On the basis of geography, the market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Asia Pacific region dominated the market in 2016 in terms of revenues, and the trend is anticipated to continue in the forecast period.

Major players in the orphan drugs market include Becton, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Hain Lifescience GmbH, Hologic Inc., Abbott Laboratories, Alere Inc., Epistem plc, Cepheid, bioMérieux SA, Akonni Biosystems Inc., LIONEX Diagnostics & Therapeutics GmbH., Danaher Corporation, Creative Diagnostics, QIAGEN, Oxford Immunotec Ltd. among others. The primary strategies applied by the market players to enhance their market share include strategic acquisitions, and new product launches, among others.

Purchase this Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=2267<ype=S

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.